COVID-19 POSITION STATEMENT: Australian and New Zealand Endocrine Surgeons

Position Statement: Endocrine Surgery during the COVID-19 Pandemic Australian and New Zealand Endocrine Surgeons & General Surgeons Australia 24 April 2020 Defining urgent endocrine surgical conditions Australia and New Zealand have done an excellent job using social distancing to mitigate the burden of COVID-19, and thus far have thankfully not seen the volume of cases and fatalities we have witnessed in other countries. The Australian Government has advised us to increase elective surgery based on urgency categories. The ANZES Executive offer the following guidelines for urgency category with regard to Endocrine Surgery, endorsed as well by our colleagues at General Surgeons Australia. 

These guidelines rely on individual judgement of surgeons and hospital executives, depending on changes in COVID-19 case incidence and availability local resources and capacity. 

Endocrine surgery urgency classification guideline 

Category 1 
• Thyroid cancer or highly suspected cancer 
• Severe Graves’ disease refractory to medical management, or with adverse reaction to antithyroid medication 
• Goitre with significant and symptomatic airway compromise 

• Hyperparathyroidism with severe hypercalcaemia >2.9 or severe symptoms 
• Hyperparathyroidism in pregnancy

• Adrenocortical cancer or highly suspected adrenocortical cancer
• Pheochromocytoma or paraganglioma that is unable to be controlled with medical management 
• Cushing’s syndrome with significant symptoms that is unable to be controlled with medical management 

Urgent Category 2 
• Goitre with significant obstructive symptoms 
• Indeterminate cytology and/or ultrasound features suggesting malignancy 

• Hyperparathyroidism with severe osteoporosis or fragility fractures 

• Functional adrenal mass causing medical comorbidity 
• Adrenal mass with suspicion of malignancy 

Standard Category 2: 
- Most other endocrine surgical procedures and indications, including: 
- Patients with low risk microcarcinoma who have chosen surgery over active surveillance, 
- Mildly symptomatic goitre 
- Surgery for well-controlled Graves’ disease. 
- Asymptomatic or mildly symptomatic primary hyperparathyroidism 

Please also refer to the COVID-19 Guidelines for Endocrine Surgery published by ANZES and GSA. 

Please look after yourselves, and reach out to us if we can support you in any way.

Kind regards, Assoc Prof Julie Miller MD FRACS President, Australian and New Zealand Endocrine Surgeons Mr Trevor Collinson FRACS President, General Surgeons Australia

Australian and New Zealand Endocrine Surgeons

Australian and New Zealand Endocrine Surgeons is a society of specialist surgeons that aims to achieve the highest standards in the practice of endocrine surgery.

Endocrine surgery includes surgery of the thyroid gland, parathyroid glands, adrenal glands and the endocrine pancreas.

The members of ANZES are specialist surgeons (Fellows of the Royal Australasian College of Surgeons) who have had further training and experience in endocrine surgery. Full members of ANZES are also members of the International Association of Endocrine Surgeons (IAES) which has approximately 400 members worldwide. ANZES has links to the Endocrine Society of Australia, to the IAES, and to other international endocrine surgical groups including the American Association of Endocrine Surgeons (AAES), the Asian Association of Endocrine Surgeons and the British Association of Endocrine Surgeons (BAES).

This website has useful information about endocrine surgery, as well as interesting historical anecdotes relating to endocrine surgery and links to other related websites

Find A Surgeon

- select country first to select state

Prediction Tools for Surgeons


Contact Us

Australian and New Zealand Endocrine Surgeons
Suite 202 AMA House
69 Christie Street

Send Email to Australian and New Zealand Endocrine Surgeons

Just Updated

The Alfred General Surgery Meeting 2019

Saturday, April 06, 2019
The Alfred General Surgery Meeting 2019 1 - 2 November 2019 Pullman Melbourne on the Park 192 Wellington Parade, Melbourne, Victoria Early registration closure: 29 September 2019 For more information and to register please visit the meeting website. (https://surgeons.eventsair.com/alfred2019/alfred19) ..Read More

RACS 88th Annual Scientific Congress

Tuesday, February 19, 2019
Save the date for the RACS 88th Annual Scientific Congress 6-10 May 2019 Centara Grand & Bangkok Convention Centre | Bangkok, Thailand  ..Read More

Save the Date: 6th Postgraduate Course in Endocrine Surgery

Thursday, October 29, 2015
Save the date for the 6th Postgraduate Course in Endcorine Surgery 24th and 25th June 2016 Parkroyal Darling Harbour Sydney (Agenda to be published soon)  ..Read More

30th and 31st of October: The Alfred General Surgery Meeting 2015

Thursday, October 29, 2015
 ..Read More

August 2013 - Symposium on the management of central compartment lymph node disease

Friday, August 09, 2013
THE ROLE OF LYMPH NODE SURGERY IN THE MANAGEMENT OF CENTRAL COMPARTMENT NODAL METASTASIS IN PAPILLARY THYROID CARCINOMA The following document summarizes a presentation given by A/Prof Mark Sywak at a Clinical Symposium on the management of central compartment lymph node disease. The symposium was held at the recent International Surgical Week, Helsinki FINLAND in August 2013.  ..Read More

August 2012 Newsletter: James Berry and His Thyroid Clinic

Thursday, August 16, 2012
HISTORICAL NOTE JAMES BERRY AND HIS THYROID CLINIC Berry’s Ligament is certainly the most well known eponymous anatomical structure of relevance to thyroid surgery, tethering the thyroid gland to the trachea and lying, as it does, at the crucial point where the recurrent laryngeal nerve is most likely to be injured. James Berry was a formidable surgeon who established a Thyroid Surgical Clinic ..Read More

July 2011 Newsletter: Rundle and His Curve

Saturday, June 11, 2011
Rundle’s curve is a well known phenomenon, found in many ophthalmology and endocrinology textbooks. It describes the natural history of the orbital changes in Graves’ ophthalmopathy. Whilst all the primary research underlying this observation was undertaken in the London, Rundle was in fact an Australian, and later returned to Sydney to make a significant contribution to the surgic ..Read More

March 2010 Newsletter: Cecil Joll and His Instruments

Monday, September 27, 2010
Joll's thyroid retractor Thyroid surgeons from last century were at the forefront of developing surgical instruments to facilitate safe and effective thyroid surgery. Such instruments remain in widespread use in all forms of surgery today. In this current era of sutureless thyroidectomy, where almost the entire procedure can be performed with a small, hand-held, disposable vessel sealin ..Read More

November 2009 Newsletter: IAES - The International Association of Endocrine Surgeons

Wednesday, January 20, 2010
The IAES owes its origins to Peter Heimann, Professor of Surgery, Bergen, Norway. He was a general surgeon with a particular interest in the thyroid gland, and it was his ambition to polarize the activities of those general surgeons interested in the endocrine system into a special group within the Société Internationale de Chirurgie (SIC). In 1978, Peter Heimann wrote to some of his frien ..Read More

September 2009 Newsletter: A Tale of Two Celts

Wednesday, January 20, 2010
Immunogenic thyrotoxicosis is commonly referred to as Graves’ disease after the Irish physician Robert Graves. That however is a case of mistaken eponymous attribution to the wrong Celt, and the disorder should really be called Parry’s disease after the Welsh physician, Caleb Parry, who was the first to describe the clinical features. Robert Graves was born in Dublin in 1797, the son  ..Read More

Quick Contact

Captcha Image